FDA
approval
· 2023-08-02
FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
Summary
The FDA approved a supplemental ANDA for a generic formulation of bupropion hydrochloride by Amneal Pharmaceuticals of New York LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)